您的当前位置:首页 > 行业数据 > 中长期治疗艾加莫德安全性数据优异
图片属性
图片格式:PNG 图片大小:198KB 图片尺寸:1126*713
同报告图片
 / 4
中长期治疗艾加莫德安全性数据优异_第1页
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
中长期治疗艾加莫德安全性数据优异_第2页
中长期治疗艾加莫德安全性数据优异_第3页
中长期治疗艾加莫德安全性数据优异_第4页
中长期治疗艾加莫德安全性数据优异_第5页
所属报告: 再鼎医药-港股公司首次覆盖报告:“License~in+自主研发”双轮驱动即将进入发展新阶段-250610(39页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠